December 5, 2017 Sophia Vida
Biotech & Pharma

Neuralstem Explodes on Positive Phase 2 Clinical Data

Shares of Neuralstem were exploding in Tuesday trading and closed the day up 175% after revealing successful updated Phase 2 clinical data in its depressive disorder trial of NSI-189. The results were presented at the 56th American College of Neuropsychopharmacology (ACNP) Annual meeting in a poster presentation entitled, “A Phase 2, Double-Blind, Placebo-Controlled Study of … Continue reading “Neuralstem Explodes on Positive Phase 2 Clinical Data”